FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1636735331> ?p ?o ?g. }

• W1636735331 endingPage "9" @default.
• W1636735331 startingPage "7" @default.
• W1636735331 abstract "Sickle cell disease in Brazil, when explained in medical, genetic, social or anthropological terms, has a strong relationship with the introduction of Black Africans in our country. In 1932, Nina Rodrigues a Brazilian historian, researched about the origin of the African slaves that came to Brazil. He used data obtained from the customs department of the port in Salvador, Bahia. This researcher concluded that almost all of the African slaves were from two regions on the west coast of Africa: the Mina Coast (approximately the region of Benin, Togo and Ghana) and Angola.(1) Recent studies using mitochondrial DNA analysis, performed by Sales in 2004, showed that 58.8% of the Brazilian Black people originate from Central West Africa which includes Angola, and 32.1% come from West Africa that includes some regions that are believed to have belonged to the Mina Coast.(2) Molecular analysis of Hb S haplotypes were made by several Brazilian researchers in different regions of the country.(3-8) These analyses enable the African origin of Brazilian Black people to be tracked by means of beta S globin gene (Table 1).Table 1Frequency (%) of haplotypes of Hb S in different cities and states of BrazilStudies showed that the Bantu and Benin haplotypes are prevalent however the frequencies vary according to the region studied. These results reveal a heterogeneous employment of slave workers in the northeastern states of Brazil with incredibly similar results obtained in the cities of Rio de Janeiro and Salvador, as well as in Belem and Campinas.Knowledge of the Hb S haplotypes of patients with sickle cell anemia is an important molecular marker of the severity of disease, the clinical and hematological repercussions, as well as of the Hb Fetal concentrations in these patients.(9,10) Thus, this article aims at emphasizing the necessity of associating sickle cell disease with its evolution in Brazilian science, setting in the context of Brazilian public health policies.The first article published in Brazil in which the cases were probably of sickle cell disease was made by Doctor Cruz Jobim in Rio de Janeiro.(11) This paper had a social basis because the author emphasized that it is a very specific illness that mostly affects poor black people. After the effectively scientific publication about the clinic characteristics of sickle cell disease described in 1910 by Herrick(12) and the discovery of the distortion of sickled cells that was made by Emmel in 1917,(13) there was a gap of almost thirty years with few scientific advances in sickle cell disease. So a special mention must be made of Accioly who, in 1947, suggested in a scientific article published in Brazil that sickle cell anemia must be the homozygous condition of the gene that causes the sickling phenomenon.(14) The genetic interest about sickle cell disease in the Brazilian population called the attention of the geneticists Tondo and Salzano. These two researchers studied abnormal hemoglobins in the Brazilian Indian population in 1960(15) and the Brazilian Black people in 1962,(16) in particular Hb S. In 1965, Araujo studied the prevalence of hemoglobinopathies in patients of Hospital das Clinicas in Sao Paulo and concluded that the sickle cell trait (Hb AS) was the most prevalent abnormal hemoglobin, especially in the black people.(17) However, only in 1969, Marinho presented a dissertation to the Brazilian Medical Academy about the clinical characteristics of sickle cell disease of patients from the Instituto de Hematologia Arthur Siqueira Cavalcanti (currently HEMORIO) in Rio de Janeiro.(18) The scientific setting that suggested that sickle cell disease is of importance to public health stimulated Naoum et al.(19) to carry out a scientific study to detect abnormal hemoglobins in the state of Sao Paulo. During the period from 1978 to 1982 they analyzed 18 thousand individuals from 19 cities that were characterized as important medical centers in the state of Sao Paulo. Among the different abnormal hemoglobins that were identified, the sickle cell trait was prevalent in 1.6% of the total population (White and Black); the frequency of sickle cell trait in black individuals was 9.0%, while in white people was 0.96%. This scientific experience stimulated the author of this article to create an educational program on the laboratorial identification of hemoglobinopathies, especially sickle cell disease, aimed at healthcare professionals in several Brazilian regions. With significant collaboration of Claudia Regina Bonini Domingos, Ivan de Lucena Angulo and other colleagues, courses were started in 1980 and were offered for 25 years without interruption. In 1981, Hutz carried out one of the most complete studies on the natural history of sickle cell anemia in Brazil.(20) She used the data of 409 patients registered in the HEMORIO in Rio de Janeiro; the results of this study are medical references until today. In this same period two pioneer researches were performed to identify Hb S in newborn babies. The first study was made in 1976 by Ramalho et al. in newborns from Campinas(21) and the second study was made in 1986 by Ruiz et al. with newborns from Santos.(22)The gradual development in the diagnosis of the sickle cell disease stimulated Ramalho to publish a book about the importance of this disease to public health in Brazil.(23) The possibility that this disease may be a real problem in public health caused both scientific and political measures. One pioneer study was organized in the 1990s by Bandalise et al. in Campinas, the results of which were published in 2004.(24) The Campinas experience made the local government of the city establish the first screening program of newborns in Brazil to detect sickle cell anemia.(25) Special mention must go to Jose Nelio Januario who, in 1993, founded the Nucleo de Acoes e Pesquisas em Apoio ao Diagnostico (NUPAD) in Belo Horizonte, MG. During 17 years NUPAD analyzed more than four million blood samples of newborns with the purpose of identifying sickle cell disease and other important diseases, such as congenital hypothyroidism, phenylketonuria and cystic fibrosis.The result of all this effort over many years with scattered and diverse studies on the general aspects of sickle cell disease was compensated in 2001 with the publication of a decree by the Health Ministry of Brazil that established the National Newborn Screening Program.(26) The immediate success of this program caused the Health Ministry of Brazil to extend to the government healthcare plan in 2005.(27,28) In 2010, during the V Brazilian Symposium of Sickle Cell Disease and other Hemoglobinopathies, in Belo Horizonte, MG, with the support of the Health Ministry of Brazil, was revealed that about 3500 newborns are born every year with sickle cell disease in Brazil and that 200 thousand are born with the sickle cell trait. The highest prevalence of newborns with sickle cell disease occurs in Bahia (Table 2).Table 2Prevalence of sickle cell disease calculated from data of newborns from 16 Brazilian states in 2008 of the National Newborn Screening Program of the Brazilian Health MinistryTo complete this article is also very important to recognize the effort that many Brazilian researchers have dedicated to study sickle cell disease and other hemoglobinopathies in different regions of Brazil, as well as the associations of sickle cell anemia formed by patients and collaborates, and scientific societies, in particular the Brazilian Society of Hematology and Hemotherapy and the Brazilian College of Hematology, recently merged as the Brazilian Association of Hematology and Hemotherapy." @default.
• W1636735331 created "2016-06-24" @default.
• W1636735331 creator A5010442696 @default.
• W1636735331 date "2011-01-01" @default.
• W1636735331 modified "2023-09-29" @default.
• W1636735331 title "Sickle cell disease" @default.
• W1636735331 cites W2034646185 @default.
• W1636735331 cites W2044789512 @default.
• W1636735331 cites W2055152730 @default.
• W1636735331 cites W2062959787 @default.
• W1636735331 cites W2070511600 @default.
• W1636735331 cites W2123970067 @default.
• W1636735331 cites W2137164532 @default.
• W1636735331 cites W2161390068 @default.
• W1636735331 cites W2169645025 @default.
• W1636735331 cites W2170703657 @default.
• W1636735331 cites W2436361762 @default.
• W1636735331 cites W56082756 @default.
• W1636735331 cites W2081632499 @default.
• W1636735331 doi "https://doi.org/10.5581/1516-8484.20110006" @default.
• W1636735331 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3521427" @default.
• W1636735331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23284235" @default.
• W1636735331 hasPublicationYear "2011" @default.
• W1636735331 type Work @default.
• W1636735331 sameAs 1636735331 @default.
• W1636735331 citedByCount "13" @default.
• W1636735331 countsByYear W16367353312013 @default.
• W1636735331 countsByYear W16367353312015 @default.
• W1636735331 countsByYear W16367353312016 @default.
• W1636735331 countsByYear W16367353312017 @default.
• W1636735331 countsByYear W16367353312019 @default.
• W1636735331 countsByYear W16367353312020 @default.
• W1636735331 countsByYear W16367353312021 @default.
• W1636735331 countsByYear W16367353312023 @default.
• W1636735331 crossrefType "journal-article" @default.
• W1636735331 hasAuthorship W1636735331A5010442696 @default.
• W1636735331 hasBestOaLocation W16367353312 @default.
• W1636735331 hasConcept C126322002 @default.
• W1636735331 hasConcept C1491633281 @default.
• W1636735331 hasConcept C177713679 @default.
• W1636735331 hasConcept C2779134260 @default.
• W1636735331 hasConcept C41008148 @default.
• W1636735331 hasConcept C54355233 @default.
• W1636735331 hasConcept C70721500 @default.
• W1636735331 hasConcept C71924100 @default.
• W1636735331 hasConcept C86803240 @default.
• W1636735331 hasConceptScore W1636735331C126322002 @default.
• W1636735331 hasConceptScore W1636735331C1491633281 @default.
• W1636735331 hasConceptScore W1636735331C177713679 @default.
• W1636735331 hasConceptScore W1636735331C2779134260 @default.
• W1636735331 hasConceptScore W1636735331C41008148 @default.
• W1636735331 hasConceptScore W1636735331C54355233 @default.
• W1636735331 hasConceptScore W1636735331C70721500 @default.
• W1636735331 hasConceptScore W1636735331C71924100 @default.
• W1636735331 hasConceptScore W1636735331C86803240 @default.
• W1636735331 hasIssue "1" @default.
• W1636735331 hasLocation W16367353311 @default.
• W1636735331 hasLocation W16367353312 @default.
• W1636735331 hasLocation W16367353313 @default.
• W1636735331 hasLocation W16367353314 @default.
• W1636735331 hasLocation W16367353315 @default.
• W1636735331 hasLocation W16367353316 @default.
• W1636735331 hasOpenAccess W1636735331 @default.
• W1636735331 hasPrimaryLocation W16367353311 @default.
• W1636735331 hasRelatedWork W1839838842 @default.
• W1636735331 hasRelatedWork W1980950179 @default.
• W1636735331 hasRelatedWork W2076985335 @default.
• W1636735331 hasRelatedWork W2090704721 @default.
• W1636735331 hasRelatedWork W2124125394 @default.
• W1636735331 hasRelatedWork W2315324320 @default.
• W1636735331 hasRelatedWork W2748952813 @default.
• W1636735331 hasRelatedWork W2899084033 @default.
• W1636735331 hasRelatedWork W2919291229 @default.
• W1636735331 hasRelatedWork W2991533465 @default.
• W1636735331 hasVolume "33" @default.
• W1636735331 isParatext "false" @default.
• W1636735331 isRetracted "false" @default.
• W1636735331 magId "1636735331" @default.
• W1636735331 workType "article" @default.